EATG » AIDS 2018

AIDS 2018

AIDS 2018: Terrence Higgins Trust launches Access Fund to support people who can’t afford HIV prevention drug PrEP

The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland. The fund, which launches this autumn, intends to support…

AIDS 2018: Hologic’s Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Program focuses on infectious disease assays - including HIV - for countries where critical testing is needed most MARLBOROUGH, Mass., July 25, 2018 -- Hologic, Inc. (NASDAQ: HOLX) announced today the…

AIDS 2018: Studies raise concerns about policies seeking to “end demand” for sex work

Analysis of laws in Canada and France 26 July 2018 (Amsterdam, the Netherlands) – Research suggests that “end demand” laws are reducing demand for HIV services, according to panellists sharing the…

AIDS 2018: New data show dramatic progress in Namibia toward HIV epidemic control and substantial gaps in Cote d’Ivoire and Cameroon

PEPFAR-supported surveys reveal several countries have made significant gains in HIV prevention, treatment, and viral suppression and provide critical insights into key regional and population disparities Amsterdam, The Netherlands (July…

At AIDS 2018, advocates want action from world leaders to end TB-HIV

Amsterdam, The Netherlands (July 23, 2018) — In preparation for the first ever United Nation’s High-Level Meeting (UNHLM) on tuberculosis (TB), to be held September 26, in New York, advocates…

AIDS 2018: NAM reports, 26 July

The 22nd International AIDS Conference (AIDS 2018) is being held in Amsterdam, the Netherlands, from 23 to 27 July 2018. NAM reports: Progress against HIV in young people lags behind…

AIDS 2018: Benefits of early antiretroviral therapy in HIV-infected children

The initial findings of the ANRS CLEAC coordinated by Pierre Frange (Hôpital Necker – AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children…

AIDS 2018: Women tackle tough choice after dolutegravir birth defects

AMSTERDAM — The rate of neural tube defects in infants was seven times higher than expected when women with HIV were taking dolutegravir (Tivicay, GlaxoSmithKline) at the time of conception,…

AIDS 2018: 20 of the world’s leading researchers say scientific evidence does not support HIV criminalization laws

25 July 2018 (Amsterdam, the Netherlands) – Twenty of the world’s leading HIV scientists have launched an evidence-based consensus that systematically refutes the rationale for laws that criminalize HIV transmission.…

AIDS 2018: Fauci: HIV remission free of antiretroviral therapy is a feasible goal

NIAID director will give special session lecture at AIDS 2018 Conference. Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S.…

1 2 3 5